Medicare Reform Scoring For Savings From Competition Is Difficult - CBO
Analyzing the impact of private competition on the cost of Medicare reform proposals remains difficult, Congressional Budget Office Director Dan Crippen told the Senate Budget Committee Sept. 4.
You may also be interested in...
The House Energy & Commerce and Ways & Means Committees plan to introduce a joint Medicare prescription drug benefit bill in late September, which could allow floor action in October.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials